Research Paper Volume 16, Issue 10 pp 8944—8964
SLAMF8 can predict prognosis of pan-cancer and the immunotherapy response effectivity of gastric cancer
Figure 12. The mutation of SLAMF8 gene in pan-cancer. (A) The mutation of SLAMF8 gene in BLCA. (B) The mutation of SLAMF8 gene in BRCA. (C) The mutation of SLAMF8 gene in CESC. (D) The mutation of SLAMF8 gene in GBM. (E) The mutation of SLAMF8 gene in LIHC. (F) The mutation of SLAMF8 gene in LUAD. (G) The mutation of SLAMF8 gene in LUSC. (H) The mutation of SLAMF8 gene in SKCM. (I) The mutation of SLAMF8 gene in STAD. (J) The mutation of SLAMF8 gene in THCA.